Matthew Foxton
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Liver Disease and Transplantation, Organ Transplantation Techniques and Outcomes, Liver Diseases and Immunity
Most-Cited Works
- → Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score(2018)159 cited
- → Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis(2019)123 cited
- → Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs(2010)109 cited
- → Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls(2022)92 cited
- → Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidase(2016)61 cited
- → Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature(2020)21 cited
- → Rifaximin is an efficacious treatment for the parkinsonian phenotype of hepatic encephalopathy(2013)15 cited
- → The association of pretransplant ferritin level with waiting list and post-transplant survival. Does ferritin actually predict outcome?(2013)13 cited
- → Impact of comorbidity on waiting list and post-transplant outcomes in patients undergoing liver retransplantation(2017)11 cited
- → Change in model for end-stage liver disease score on the transplant waiting list predicts survival in patients undergoing liver transplantation(2006)11 cited